The Leadership Team at eXIthera drives the strategic vision and operational excellence of the company, focusing on advancing innovative therapies for anticoagulation through Factor XIa inhibition. They leverage their expertise in translational medicine and medical affairs to guide research initiatives, ensure regulatory compliance, and foster partnerships that enhance product development and market positioning.